Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
Krystal Biotech (NASDAQ:KRYS) announced its participation in the upcoming Cantor Global Healthcare Conference 2025, taking place in New York on September 4, 2025. Chairman and CEO Krish S. Krishnan will participate in a fireside chat at 10:20 AM ET and conduct investor meetings throughout the day.
The presentation will be accessible via webcast and will be made available on the Investors section of the company's website.
Krystal Biotech (NASDAQ:KRYS) ha comunicato la sua partecipazione al Cantor Global Healthcare Conference 2025, che si terrà a New York il 4 settembre 2025. Il presidente e CEO Krish S. Krishnan prenderà parte a una sessione informale (fireside chat) alle 10:20 AM ET e terrà incontri con gli investitori durante l'intera giornata.
La presentazione sarà trasmessa in webcast e resa disponibile nella sezione Investors del sito web della società.
Krystal Biotech (NASDAQ:KRYS) anunció su participación en la Cantor Global Healthcare Conference 2025, que se celebrará en Nueva York el 4 de septiembre de 2025. El presidente y CEO Krish S. Krishnan participará en una charla informal (fireside chat) a las 10:20 AM ET y llevará a cabo reuniones con inversores a lo largo del día.
La presentación estará disponible por webcast y se publicará en la sección Investors del sitio web de la compañía.
Krystal Biotech (NASDAQ:KRYS)는 2025년 9월 4일 뉴욕에서 열리는 Cantor Global Healthcare Conference 2025에 참가한다고 발표했습니다. 회장 겸 CEO Krish S. Krishnan은 동부시간(ET) 오전 10:20에 진행되는 파이어사이드 챗에 참여하고 하루 종일 투자자 미팅을 진행할 예정입니다.
발표는 웹캐스트로 제공되며 회사 웹사이트의 Investors 섹션에서 확인할 수 있습니다.
Krystal Biotech (NASDAQ:KRYS) a annoncé sa participation à la Cantor Global Healthcare Conference 2025, qui se tiendra à New York le 4 septembre 2025. Le président et CEO Krish S. Krishnan prendra part à un fireside chat à 10:20 AM ET et tiendra des rencontres avec des investisseurs tout au long de la journée.
La présentation sera accessible en webcast et disponible dans la rubrique Investors du site web de la société.
Krystal Biotech (NASDAQ:KRYS) gab bekannt, dass das Unternehmen an der Cantor Global Healthcare Conference 2025 teilnimmt, die am 4. September 2025 in New York stattfindet. Vorsitzender und CEO Krish S. Krishnan wird an einem Fireside-Chat um 10:20 AM ET teilnehmen und den ganzen Tag über Investorenmeetings abhalten.
Die Präsentation wird per Webcast zugänglich sein und in der Investors-Sektion der Unternehmenswebsite veröffentlicht.
- None.
- None.
PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:20 am ET and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 10:20 am ET on Thursday, September 4, 2025 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy, and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com
FAQ
When is Krystal Biotech (KRYS) presenting at the Cantor Global Healthcare Conference 2025?
Who will represent Krystal Biotech (KRYS) at the Cantor Healthcare Conference?
How can investors access Krystal Biotech's (KRYS) presentation at the Cantor Conference?
What type of presentation will Krystal Biotech (KRYS) give at the Cantor Conference?
